A new treatment for sleep apnoea is changing lives in the UK, particularly for those who struggle with traditional methods like CPAP machines. Catherine Turnbull, one of the first patients to receive a hypoglossal nerve stimulation (HGNS) device at Swindon’s Great Western Hospital, describes the profound impact it has had on her life. Previously, she dreaded bedtime due to the discomfort of her CPAP machine, but now she looks forward to sleep without interruptions.
The HGNS device works by stimulating the tongue to keep the airway open during sleep, a significant advancement for patients who cannot tolerate CPAP. This treatment is still relatively new in the UK, with strict criteria for eligibility, meaning it is reserved for severe cases. However, its introduction could pave the way for broader acceptance and availability, potentially transforming the lives of many who suffer from this condition.
Sleep apnoea can lead to serious health issues, including fatigue, mood swings, and relationship problems due to loud snoring. The new treatment not only alleviates these symptoms but also addresses the underlying causes, offering a more effective solution for those affected. As awareness grows, it may encourage more people to seek diagnosis and treatment, reducing the stigma associated with sleep disorders.
Healthcare professionals are optimistic about the future of sleep apnoea treatment in the UK. With more hospitals adopting this technology, patients like Turnbull hope that their experiences will inspire others to pursue effective solutions, ultimately improving quality of life for many across the country.
Source: BBC News
